Parfrey N A, Hutchins G M
Am J Med. 1986 Nov;81(5):825-9. doi: 10.1016/0002-9343(86)90353-0.
The mucopolysaccharidoses are a group of clinically progressive, heritable, lysosomal storage disorders. Many organ systems are affected due to widespread accumulation of incompletely degraded mucopolysaccharide. The novel finding of hepatic fibrosis in each of six cases of mucopolysaccharidosis examined at autopsy (including examples of Hurler syndrome, Hunter syndrome, and Sanfilippo syndrome) is described. In each instance, the liver was diffusely involved by fibrosis that outlined the lobules, and there was extensive hepatocyte and Kupffer cell vacuolization. The pattern of hepatic fibrosis is not explained by either cardiac failure or drug toxicity. It is hypothesized that the hepatic fibrosis is due to the abnormal accumulation of a hepatotoxic metabolite. The frequency and severity of liver disease in the mucopolysaccharidoses deserve further study. In particular, with the advent of bone marrow transplantation as therapy for some of the mucopolysaccharidoses, the question of whether cirrhosis develops in these patients and, if so, what its rate of progression is, should be addressed.
黏多糖贮积症是一组临床上呈进行性发展的、可遗传的溶酶体贮积症。由于不完全降解的黏多糖广泛蓄积,许多器官系统都受到影响。本文描述了在6例经尸检的黏多糖贮积症病例(包括Hurler综合征、Hunter综合征和Sanfilippo综合征的病例)中均发现肝纤维化这一新颖的情况。在每个病例中,肝脏均被弥漫性纤维化累及,纤维化勾勒出小叶轮廓,并且存在广泛的肝细胞和库普弗细胞空泡化。肝纤维化的模式既不能用心力衰竭也不能用药物毒性来解释。据推测,肝纤维化是由于一种肝毒性代谢产物的异常蓄积所致。黏多糖贮积症中肝脏疾病的发生率和严重程度值得进一步研究。特别是,随着骨髓移植作为某些黏多糖贮积症的治疗方法的出现,这些患者是否会发生肝硬化以及如果发生其进展速度如何的问题,应该得到解决。